EU-V: U32 Offizielles Ratsdokument
Proposal for a Regulation of the European Parliament and of the Council on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices [12971/20 - COM(2020) 725 final] Proposal for a Regulation of the European Parliament and of the Council amending Regulation (EC) No 851/2004 establishing a European Centre for disease prevention and control [12972/20 - COM(2020) 726 final] Proposal for a Regulation of the European Parliament and of the Council on serious cross-border threats to health and repealing Decision No 1082/2013/EU [12973/20 - COM(2020) 727 final] - Opinion on the application of the Principles of Subsidiarity and Proportionality/Cover note from the Italian Parliament
Erstellt am 26.05.2021 von: Beschäftigung, Sozialpolitik und Gesundheit
Eingelangt am 26.05.2021, U32 Übermittlung
- RAT: 9123/21 PDF
Linkart | Link |
---|---|
COM
Kommission |
COM(2020) 725 |
COM
Kommission |
COM(2020) 726 |
COM
Kommission |
COM(2020) 727 |
INT
Interinstitutionelle Zahl |
2020/0320 (COD) |
INT
Interinstitutionelle Zahl |
2020/0321 (COD) |
INT
Interinstitutionelle Zahl |
2020/0322 (COD) |
RAT
Rat |
12971/20 |
RAT
Rat |
12972/20 |
RAT
Rat |
12973/20 |
RMA
Ratsmateriencodes |
CODEC 765 |
RMA
Ratsmateriencodes |
COMPET 421 |
RMA
Ratsmateriencodes |
INST 200 |
RMA
Ratsmateriencodes |
MI 387 |
RMA
Ratsmateriencodes |
PARLNAT 113 |
RMA
Ratsmateriencodes |
PHARM 100 |
RMA
Ratsmateriencodes |
PROCIV 67 |
RMA
Ratsmateriencodes |
SAN 322 |
BES
Beschlusse |
No 1082/2013/EU |
VER
Verordnungen |
851/2004 |
Datum | EU-Datenbanknr. | Dokument der EU-Vorlage | Sprache | Einstufung |
---|---|---|---|---|
26.05.2021 | 62260/EU XXVII.GP |
|
mehrsprachig | PUBLIC |
Interinstitutionelle Zahl
Der Link führt zu den einzelnen Dokumenten dieses Vorhabens. |
Link |
---|---|
2020/0320 COD | Legislative Observatory |
2020/0321 COD | Legislative Observatory |
2020/0322 COD | Legislative Observatory |
Code | Sachgebiet |
---|---|
SAN 322 | Gesundheit |
PHARM 100 | Pharmazie |
MI 387 | Binnenmarkt |
COMPET 421 | Wettbewerbsfähigkeit (Binnenmarkt/Industrie) |
PROCIV 67 | Katastrophenschutz |
COVID-19 225 | COVID-19 |
CODEC 765 | Mitentscheidungsverfahren |
INST 200 | Institutionelle Fragen |
PARLNAT 113 | Zuleitung an die nationalen Parlamente |